SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-111052
Filing Date
2019-04-18
Accepted
2019-04-18 17:15:55
Documents
5
Period of Report
2019-05-23
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d717179ddef14a.htm DEF 14A 312112
2 GRAPHIC g717179g0418092346304.jpg GRAPHIC 3785
3 GRAPHIC g717179g0418092910573.jpg GRAPHIC 6390
4 GRAPHIC g717179g0418092910714.jpg GRAPHIC 1428
5 GRAPHIC g717179g0418092910824.jpg GRAPHIC 7178
  Complete submission text file 0001193125-19-111052.txt   339937
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 19756628
SIC: 2834 Pharmaceutical Preparations